New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - buserelin acetate 1 mg/ml - nasal spray solution - 1 mg/ml - active: buserelin acetate 1 mg/ml

Canada - English - Health Canada

hoechst canada inc. - buserelin (buserelin acetate) - liquid - 1mg - buserelin (buserelin acetate) 1mg - miscellaneous therapeutic agents

Canada - English - Health Canada

hoechst canada inc. - buserelin acetate - spray - 1mg - buserelin acetate 1mg - miscellaneous therapeutic agents

Canada - English - Health Canada

hoechst roussel canada inc. - buserelin (buserelin acetate) - liquid - 1mg - buserelin (buserelin acetate) 1mg - miscellaneous therapeutic agents

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - buserelin acetate - unknown - buserelin acetate hormone-gonadotrophin active 0.0 - active constituent

Malta - English - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - buserelin acetate - solution for injection - buserelin acetate 1 mg/ml - pituitary and hypothalamic hormones and analogues

Canada - English - Health Canada

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.

Israel - English - Ministry of Health

sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml